NO20092373L - Substituerte heteroarylpyridopyrimidonderivater - Google Patents

Substituerte heteroarylpyridopyrimidonderivater

Info

Publication number: NO20092373L
Authority: NO; Norway
Prior art keywords: group; atom; alkyl group; hydrogen atom; optionally substituted
Prior art date: 2006-12-20

Application number

NO20092373A

Other languages

English (en)

Norwegian (no)

Inventor

Aude Fayol

Thierry Gallet

Alistair Lochead

Mourad Saady

Corinne Veronique

Philippe Yaiche

Original Assignee

Mitsubishi Tanabe Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-20

Filing date

2009-06-22

Publication date

2009-08-28

2009-06-22 Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp

2009-08-28 Publication of NO20092373L publication Critical patent/NO20092373L/no

Links

125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
125000005843 halogen group Chemical group 0.000 abstract 3
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004430 oxygen atom Chemical group O* 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
229910052717 sulfur Inorganic materials 0.000 abstract 2
125000004434 sulfur atom Chemical group 0.000 abstract 2
208000024827 Alzheimer disease Diseases 0.000 abstract 1
102000001267 GSK3 Human genes 0.000 abstract 1
108060006662 GSK3 Proteins 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000003449 preventive effect Effects 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Dermatology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Tropical Medicine & Parasitology (AREA)
Cardiology (AREA)
Plant Pathology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Emergency Medicine (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)

NO20092373A 2006-12-20 2009-06-22 Substituerte heteroarylpyridopyrimidonderivater NO20092373L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06291995A EP1939187A1 (en)	2006-12-20	2006-12-20	Substituted heteroaryl pyridopyrimidone derivatives
PCT/IB2007/004409 WO2008078196A2 (en)	2006-12-20	2007-12-20	Substituted heteroaryl pyridopyrimidone derivatives

Publications (1)

Publication Number	Publication Date
NO20092373L true NO20092373L (no)	2009-08-28

Family

ID=38002236

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20092373A NO20092373L (no)	2006-12-20	2009-06-22	Substituerte heteroarylpyridopyrimidonderivater

Country Status (16)

Country	Link
US (1)	US8198287B2 (pt)
EP (2)	EP1939187A1 (pt)
JP (1)	JP2010513463A (pt)
KR (1)	KR20090102756A (pt)
CN (1)	CN101563328B (pt)
AU (1)	AU2007337826A1 (pt)
BR (1)	BRPI0721058A2 (pt)
CA (1)	CA2672564A1 (pt)
EA (1)	EA200970598A1 (pt)
IL (1)	IL198524A (pt)
MX (1)	MX2009006024A (pt)
NO (1)	NO20092373L (pt)
NZ (1)	NZ576894A (pt)
TW (1)	TW200831099A (pt)
WO (1)	WO2008078196A2 (pt)
ZA (1)	ZA200903237B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2138492A1 (en) *	2008-06-26	2009-12-30	Sanofi-Aventis	Substituted pyrimidin-4-one derivatives
EP2138494A1 (en) *	2008-06-26	2009-12-30	Sanofi-Aventis	Substituted alkyl pyrimidin-4-one derivatives
DE102008038221A1 (de)	2008-08-18	2010-02-25	Merck Patent Gmbh	7-Azaindolderivate
DE102008038220A1 (de)	2008-08-18	2010-02-25	Merck Patent Gmbh	Oxadiazolderivate
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
AU2011261164A1 (en) *	2010-06-01	2012-12-13	The University Of Queensland	Haematopoietic-prostaglandin D2 synthase inhibitors
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
FR2992316A1 (fr) *	2012-06-22	2013-12-27	Sanofi Sa	Derives de pyrimidinones, leur preparation et leur application en therapeutique
ES2821010T3 (es)	2015-12-09	2021-04-23	Cadent Therapeutics Inc	Moduladores heteroaromáticos del receptor NMDA y usos de los mismos
US9815850B2 (en) *	2016-02-05	2017-11-14	Denali Therapeutics Inc.	Compounds, compositions and methods
AU2017314083B2 (en)	2016-08-15	2020-12-10	Bayer Aktiengesellschaft	Condensed bicyclic heterocycle derivatives as pest control agents
LT3552017T (lt)	2016-12-09	2022-05-10	Denali Therapeutics Inc.	Junginiai, naudotini kaip ripk1 inhibitoriai
AU2017382339B2 (en) *	2016-12-22	2024-02-15	Novartis Ag	NMDA receptor modulators and uses thereof
MA49014A (fr) *	2017-03-21	2020-02-05	Arbutus Biopharma Corp	Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant
PT3830092T (pt)	2018-08-03	2023-07-25	Novartis Ag	Moduladores do recetor nmda heteroaromáticos e suas utilizações
CN109748914B (zh) *	2018-12-29	2021-05-25	上海珂臻医药科技有限公司	吡啶并嘧啶类化合物及其应用
EP4463229A1 (en)	2022-01-12	2024-11-20	Denali Therapeutics Inc.	Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG13192A (en)	1976-02-10	1982-12-31	Rhone Poulenc Ind	Nouveaux derives du dithiole-1,2 leur preparation et les compositions qui les contiennent
US5629322A (en)	1994-11-15	1997-05-13	Merck & Co., Inc.	Cyclic amidine analogs as inhibitors of nitric oxide synthase
WO2003027115A1 (en) *	2001-09-21	2003-04-03	Sanofi-Synthelabo	Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
EP1460075A1 (en) *	2003-03-21	2004-09-22	Sanofi-Synthelabo	Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
EP1460076A1 (en) *	2003-03-21	2004-09-22	Sanofi-Synthelabo	Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives

2006
- 2006-12-20 EP EP06291995A patent/EP1939187A1/en not_active Withdrawn
2007
- 2007-12-18 TW TW096148482A patent/TW200831099A/zh unknown
- 2007-12-20 NZ NZ576894A patent/NZ576894A/en not_active IP Right Cessation
- 2007-12-20 CN CN2007800468908A patent/CN101563328B/zh not_active Expired - Fee Related
- 2007-12-20 EP EP07870445A patent/EP2121635A2/en not_active Withdrawn
- 2007-12-20 AU AU2007337826A patent/AU2007337826A1/en not_active Abandoned
- 2007-12-20 EA EA200970598A patent/EA200970598A1/ru unknown
- 2007-12-20 MX MX2009006024A patent/MX2009006024A/es active IP Right Grant
- 2007-12-20 WO PCT/IB2007/004409 patent/WO2008078196A2/en not_active Ceased
- 2007-12-20 ZA ZA200903237A patent/ZA200903237B/xx unknown
- 2007-12-20 CA CA002672564A patent/CA2672564A1/en not_active Abandoned
- 2007-12-20 BR BRPI0721058-2A patent/BRPI0721058A2/pt not_active IP Right Cessation
- 2007-12-20 KR KR1020097012761A patent/KR20090102756A/ko not_active Withdrawn
- 2007-12-20 JP JP2009542272A patent/JP2010513463A/ja not_active Withdrawn
2009
- 2009-05-03 IL IL198524A patent/IL198524A/en not_active IP Right Cessation
- 2009-06-18 US US12/487,270 patent/US8198287B2/en active Active
- 2009-06-22 NO NO20092373A patent/NO20092373L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP2121635A2 (en)	2009-11-25
IL198524A0 (en)	2010-02-17
US8198287B2 (en)	2012-06-12
ZA200903237B (en)	2010-08-25
TW200831099A (en)	2008-08-01
AU2007337826A1 (en)	2008-07-03
EA200970598A1 (ru)	2009-12-30
NZ576894A (en)	2011-09-30
US20090306088A1 (en)	2009-12-10
CN101563328B (zh)	2012-03-14
WO2008078196A3 (en)	2008-11-06
JP2010513463A (ja)	2010-04-30
IL198524A (en)	2013-03-24
KR20090102756A (ko)	2009-09-30
EP1939187A1 (en)	2008-07-02
MX2009006024A (es)	2009-06-30
CN101563328A (zh)	2009-10-21
WO2008078196A2 (en)	2008-07-03
CA2672564A1 (en)	2008-07-03
BRPI0721058A2 (pt)	2014-02-25

Legal Events

Date	Code	Title	Description
2013-07-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
EA200970598A1 (ru)	2009-12-30	Замещенные производные гетероарилпиридопиримидона
NO20054330L (no)	2005-12-21	8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
CY1112642T1 (el)	2016-02-10	Παραγωγα 4-(πυριδιν-4-υλο)-1η-[1,3,5]τριαζιν-2-ονης ως αναστολεις της gsκ3-βετα για τη θεραπεια των νευροεκφυλιστικων ασθενειων
AR053082A1 (es)	2007-04-25	DERIVADOS 8-PERFLUOROALQUIL-6,7,8,9-TETRAHIDROPIRIMIDO[1,2-A]PIRIMIDIN-4-ONA SUBSTITUIDOS NHIBIDORES DE GSK3BETA Y SU EMPLEO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS.
EA201070896A1 (ru)	2011-02-28	ЗАМЕЩЕННЫЕ АРИЛАМИДДИАЗЕПИНОПИРИМИДОНОВЫЕ ПРОИЗВОДНЫЕ ДЛЯ ЛЕЧЕНИЯ НЕЙРОДЕГЕНЕРАТИВНЫХ ЗАБОЛЕВАНИЙ, ВЫЗВАННЫХ АНОМАЛЬНОЙ АКТИВНОСТЬЮ GSK3β
NO20054140L (no)	2005-12-02	Dihydrospiro-[cykloalkyl]-pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse, og mellomproduktforbindelse
CY1118390T1 (el)	2017-06-28	Θεραπευτικος παραγων για τη φλεγμονωδη νοσο του εντερου
BR112012033770A2 (pt)	2016-11-22	novo derivado de nicotinamida ou sal do mesmo
EA201170094A1 (ru)	2011-08-30	Производные замещенного пиримидо[2,1-а]изохинолин-4-она
HUP0401889A2 (hu)	2005-01-28	1,8-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
NO20090952L (no)	2009-04-23	N-(aminoheteroaryl) - lh - indol-2-karboksamidderivater og fremstilling og terapeutisk anvendelse derav
BRPI0417208A (pt)	2007-02-06	derivados de 8'-piri(mi)dinil-diidroespiro-[cicloalquilamina]-pirimid o[1,2-ona]pirimidin-6-ona
MX2010008360A (es)	2010-08-30	Derivados de oxazepinopirimidona heteroarilamida sustituidos.
ATE537830T1 (de)	2012-01-15	Nicotinamid derivate und ihre verwendung als therapeutika
NZ601866A (en)	2013-12-20	Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
MX2010008362A (es)	2010-08-30	Derivados de heteroarilamida diazepinopirimidona sustituidos.
EA200970455A1 (ru)	2009-12-30	ЗАМЕЩЕННЫЙ 8-ПИПЕРИДИНИЛ-2-ПИРИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОН И ПРОИЗВОДНЫЕ 8-ПИПЕРИДИНИЛ-2-ПИРИМИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОНА
AR063988A1 (es)	2009-03-04	Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
WO2007057790A3 (en)	2007-10-11	Substituted bicyclic pyrimidone derivatives
ATE524181T1 (de)	2011-09-15	Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
NO20081944L (no)	2008-06-19	Nye benzimidazol- og benzothiazolderivater, fremgangsmate for fremstilling, anvendelse derav som legemiddel, samt farmasoytiske sammensetninger og ny anvendelse spesielt som C-Met inhibitorer
EA200300150A1 (ru)	2003-08-28	ПРОИЗВОДНЫЕ 1-[АЛКИЛ], 1-[(ГЕТЕРОАРИЛ)АЛКИЛ] И 1-[(АРИЛ)АЛКИЛ]-7-ПИРИДИНИЛ-ИМИДАЗО[1, 2-a]ПИРИМИДИН-5(1H)ОНА
NO20063865L (no)	2006-08-30	Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
AU2012342226A1 (en)	2014-06-19	1,4- dihydropyridine derivatives with Hsp modulating activity
NO20073736L (no)	2007-07-18	Nye 3-fenylpropionsyrederivater for behandlingen av diabetes